Market Cap 10.87M
Revenue (ttm) 0.00
Net Income (ttm) -11.61M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 37,600
Avg Vol 28,832
Day's Range N/A - N/A
Shares Out 2.70M
Stochastic %K 20%
Beta 2.77
Analysts Strong Sell
Price Target $27.33

Company Profile

Intensity Therapeutics, Inc., a late-stage clinical biotechnology company, engages in the provision of treatment for the regional and systemic nature of cancer relapse and metastasis in the United States. Its lead product candidate includes INT230-6, which is in Phase 3 clinical studies for the treatment of soft tissue sarcoma; and neoadjuvant and metastatic triple negative breast cancer which is in Phase 2 clinical trials. The company was incorporated in 2012 and is headquartered in Shelton, Co...

Industry: Biotechnology
Sector: Healthcare
Phone: 203 221 7381
Fax: 203 557 3023
Address:
1 Enterprise Drive, Suite 430, Shelton, United States
Jimmyjabba
Jimmyjabba Jun. 4 at 8:07 PM
$INTS I made money on this one a day spike, then a few weeks later bought more. Stupid. This is never going anywhere besides another reverse split. All these biotech the same. Lole a slodomg board. What a waste.
1 · Reply
Eric1072
Eric1072 Jun. 4 at 3:26 PM
$INTS will buy back in below $2
0 · Reply
Atrain1189
Atrain1189 Jun. 4 at 3:19 PM
$INTS what a complete shit show
0 · Reply
SBEEE
SBEEE Jun. 4 at 12:54 AM
$INTS people should bring some of their profits from $SNDK &. $MU, One day INTS is going to be on top with proven Cancer treatment.
1 · Reply
Pettechfl
Pettechfl Jun. 4 at 12:23 AM
$INTS whats going on today?
0 · Reply
SBEEE
SBEEE Jun. 3 at 11:30 AM
$INTS Right time for INTS to show performance if CEO is not a vacation anymore. https://finance.yahoo.com/sectors/healthcare/articles/abivax-drops-32-cancer-cases-192613427.html
0 · Reply
SBEEE
SBEEE Jun. 2 at 8:17 PM
$INTS https://www.biopharmaboardroom.com/interaction/1/4546/reprogramming-the-tumor-lew-bender-on-engineering-a-new-paradigm-in-cancer-therapy.html
0 · Reply
Masonic11
Masonic11 May. 29 at 12:02 AM
$ALP Exactly 💯. That girl has the moxy we need!!! The right players, the right industry, the right time. On another note, we need full float disclosure, $TRNX $TRNFQ. This mo fro can explode like noBody business. IP, green technology, oh, Portage cancer molecule, $INTS, $INO Sale. @Stopcapping, @Iggykoopa Shorty, cover before you're a 6th street bitch. Don't be sheep, put shit together. I've been here for 7 years. Muchi is no joke, think about it, 🤔. Zero institutional holdings, to 35++. We partying in south beach, then to Ibeaza. 👽🖕⛱️🍻
2 · Reply
Atrain1189
Atrain1189 May. 26 at 6:37 PM
$INTS wen moon
1 · Reply
MilsLearning
MilsLearning May. 22 at 7:41 PM
$INTS 🩳🔥🖕
0 · Reply
Latest News on INTS
Intensity Therapeutics Quarterly report: Q1 2026

May 7, 2026, 7:00 AM EDT - 4 weeks ago

Intensity Therapeutics Quarterly report: Q1 2026


Intensity Therapeutics Earnings release: Q1 2026

May 7, 2026, 7:00 AM EDT - 4 weeks ago

Intensity Therapeutics Earnings release: Q1 2026


Intensity Therapeutics Proxy statement: Proxy filing

Apr 30, 2026, 8:00 AM EDT - 5 weeks ago

Intensity Therapeutics Proxy statement: Proxy filing


Intensity Therapeutics Proxy statement: Proxy filing

Apr 30, 2026, 8:00 AM EDT - 5 weeks ago

Intensity Therapeutics Proxy statement: Proxy filing


Intensity Therapeutics Earnings release: Q4 2025

Mar 27, 2026, 7:00 AM EDT - 2 months ago

Intensity Therapeutics Earnings release: Q4 2025


Intensity Therapeutics Annual report: Q4 2025

Mar 27, 2026, 7:00 AM EDT - 2 months ago

Intensity Therapeutics Annual report: Q4 2025


Intensity Therapeutics issued new patent in the US

2026-03-24T12:12:43.000Z - 2 months ago

Intensity Therapeutics issued new patent in the US


Intensity Therapeutics provides update on INVINCIBLE-4 Study

2026-03-12T11:36:30.000Z - 3 months ago

Intensity Therapeutics provides update on INVINCIBLE-4 Study


Intensity Therapeutics regains Nasdaq compliance

2026-03-06T12:50:53.000Z - 3 months ago

Intensity Therapeutics regains Nasdaq compliance


Intensity Therapeutics Inc trading halted, news pending

2026-02-19T00:50:17.000Z - 3 months ago

Intensity Therapeutics Inc trading halted, news pending


Intensity Therapeutics announces reverse stock split

2026-02-13T14:00:18.000Z - 3 months ago

Intensity Therapeutics announces reverse stock split


Intensity Therapeutics Announces Reverse Stock Split

Feb 13, 2026, 8:58 AM EST - 3 months ago

Intensity Therapeutics Announces Reverse Stock Split


Intensity Therapeutics to present two posters ay SABCS

2025-12-11T12:55:17.000Z - 6 months ago

Intensity Therapeutics to present two posters ay SABCS


Intensity Therapeutics reports Q3 EPS (6c) vs. (25c) last year

2025-11-06T21:52:24.000Z - 7 months ago

Intensity Therapeutics reports Q3 EPS (6c) vs. (25c) last year


Intensity Therapeutics Earnings release: Q3 2025

Nov 6, 2025, 7:00 AM EST - 7 months ago

Intensity Therapeutics Earnings release: Q3 2025


Intensity Therapeutics Quarterly report: Q3 2025

Nov 6, 2025, 7:00 AM EST - 7 months ago

Intensity Therapeutics Quarterly report: Q3 2025


Intensity Therapeutics Transcript: Study Result

Oct 31, 2025, 9:00 AM EDT - 7 months ago

Intensity Therapeutics Transcript: Study Result


Intensity Therapeutics Press release: Study Result

Oct 31, 2025, 9:00 AM EDT - 7 months ago

Intensity Therapeutics Press release: Study Result


Why Is Intensity Therapeutics Stock (INTS) Up 195% Today?

2025-10-30T13:08:35.000Z - 7 months ago

Why Is Intensity Therapeutics Stock (INTS) Up 195% Today?


Intensity Therapeutics Transcript: AGM 2025

Oct 22, 2025, 10:30 AM EDT - 8 months ago

Intensity Therapeutics Transcript: AGM 2025


Intensity Therapeutics Proxy statement: Proxy Filing

Sep 9, 2025, 8:00 AM EDT - 9 months ago

Intensity Therapeutics Proxy statement: Proxy Filing


Intensity Therapeutics Proxy statement: Proxy Filing

Sep 9, 2025, 8:00 AM EDT - 9 months ago

Intensity Therapeutics Proxy statement: Proxy Filing


Intensity Therapeutics Proxy statement: Proxy Filing

Aug 28, 2025, 8:00 AM EDT - 10 months ago

Intensity Therapeutics Proxy statement: Proxy Filing


Intensity Therapeutics upgraded to Buy from Hold at Brookline

2025-08-12T19:25:20.000Z - 10 months ago

Intensity Therapeutics upgraded to Buy from Hold at Brookline


Intensity Therapeutics Earnings release: Q2 2025

Aug 7, 2025, 4:00 PM EDT - 10 months ago

Intensity Therapeutics Earnings release: Q2 2025


Intensity Therapeutics Quarterly report: Q2 2025

Aug 7, 2025, 4:00 PM EDT - 10 months ago

Intensity Therapeutics Quarterly report: Q2 2025


Intensity Therapeutics Transcript: AGM 2025

Jul 17, 2025, 10:30 AM EDT - 11 months ago

Intensity Therapeutics Transcript: AGM 2025


Intensity Therapeutics Proxy statement: Proxy Filing

Jun 2, 2025, 8:00 AM EDT - 1 year ago

Intensity Therapeutics Proxy statement: Proxy Filing


Intensity Therapeutics Proxy statement: Proxy Filing

Jun 2, 2025, 8:00 AM EDT - 1 year ago

Intensity Therapeutics Proxy statement: Proxy Filing


Intensity Therapeutics Quarterly report: Q1 2025

May 12, 2025, 6:00 PM EDT - 1 year ago

Intensity Therapeutics Quarterly report: Q1 2025


Intensity Therapeutics Earnings release: Q1 2025

May 12, 2025, 6:00 PM EDT - 1 year ago

Intensity Therapeutics Earnings release: Q1 2025


Intensity Therapeutics Annual report: Q4 2024

Mar 12, 2025, 7:00 PM EDT - 1 year ago

Intensity Therapeutics Annual report: Q4 2024


Intensity Therapeutics Earnings release: Q4 2024

Mar 12, 2025, 7:00 PM EDT - 1 year ago

Intensity Therapeutics Earnings release: Q4 2024


Intensity Therapeutics Quarterly report: Q3 2024

Nov 12, 2024, 6:00 PM EST - 1 year ago

Intensity Therapeutics Quarterly report: Q3 2024


Intensity Therapeutics Earnings release: Q3 2024

Nov 12, 2024, 6:00 PM EST - 1 year ago

Intensity Therapeutics Earnings release: Q3 2024


Intensity Therapeutics Quarterly report: Q2 2024

Aug 7, 2024, 6:00 PM EDT - 1 year ago

Intensity Therapeutics Quarterly report: Q2 2024


Intensity Therapeutics Earnings release: Q2 2024

Aug 7, 2024, 6:00 PM EDT - 1 year ago

Intensity Therapeutics Earnings release: Q2 2024


Intensity Therapeutics Transcript: AGM 2024

Jul 17, 2024, 10:00 AM EDT - 2 years ago

Intensity Therapeutics Transcript: AGM 2024


Intensity Therapeutics Proxy statement: Proxy Filing

Jun 4, 2024, 8:00 AM EDT - 2 years ago

Intensity Therapeutics Proxy statement: Proxy Filing


Intensity Therapeutics Proxy statement: Proxy Filing

Jun 4, 2024, 8:00 AM EDT - 2 years ago

Intensity Therapeutics Proxy statement: Proxy Filing


Intensity Therapeutics Quarterly report: Q1 2024

May 8, 2024, 6:00 PM EDT - 2 years ago

Intensity Therapeutics Quarterly report: Q1 2024


Intensity Therapeutics Earnings release: Q1 2024

May 8, 2024, 6:00 PM EDT - 2 years ago

Intensity Therapeutics Earnings release: Q1 2024


Intensity Therapeutics Annual report: Q4 2023

Mar 13, 2024, 7:00 PM EDT - 2 years ago

Intensity Therapeutics Annual report: Q4 2023


Intensity Therapeutics Earnings release: Q4 2023

Mar 13, 2024, 7:00 PM EDT - 2 years ago

Intensity Therapeutics Earnings release: Q4 2023


Jimmyjabba
Jimmyjabba Jun. 4 at 8:07 PM
$INTS I made money on this one a day spike, then a few weeks later bought more. Stupid. This is never going anywhere besides another reverse split. All these biotech the same. Lole a slodomg board. What a waste.
1 · Reply
Eric1072
Eric1072 Jun. 4 at 3:26 PM
$INTS will buy back in below $2
0 · Reply
Atrain1189
Atrain1189 Jun. 4 at 3:19 PM
$INTS what a complete shit show
0 · Reply
SBEEE
SBEEE Jun. 4 at 12:54 AM
$INTS people should bring some of their profits from $SNDK &. $MU, One day INTS is going to be on top with proven Cancer treatment.
1 · Reply
Pettechfl
Pettechfl Jun. 4 at 12:23 AM
$INTS whats going on today?
0 · Reply
SBEEE
SBEEE Jun. 3 at 11:30 AM
$INTS Right time for INTS to show performance if CEO is not a vacation anymore. https://finance.yahoo.com/sectors/healthcare/articles/abivax-drops-32-cancer-cases-192613427.html
0 · Reply
SBEEE
SBEEE Jun. 2 at 8:17 PM
$INTS https://www.biopharmaboardroom.com/interaction/1/4546/reprogramming-the-tumor-lew-bender-on-engineering-a-new-paradigm-in-cancer-therapy.html
0 · Reply
Masonic11
Masonic11 May. 29 at 12:02 AM
$ALP Exactly 💯. That girl has the moxy we need!!! The right players, the right industry, the right time. On another note, we need full float disclosure, $TRNX $TRNFQ. This mo fro can explode like noBody business. IP, green technology, oh, Portage cancer molecule, $INTS, $INO Sale. @Stopcapping, @Iggykoopa Shorty, cover before you're a 6th street bitch. Don't be sheep, put shit together. I've been here for 7 years. Muchi is no joke, think about it, 🤔. Zero institutional holdings, to 35++. We partying in south beach, then to Ibeaza. 👽🖕⛱️🍻
2 · Reply
Atrain1189
Atrain1189 May. 26 at 6:37 PM
$INTS wen moon
1 · Reply
MilsLearning
MilsLearning May. 22 at 7:41 PM
$INTS 🩳🔥🖕
0 · Reply
Pettechfl
Pettechfl May. 21 at 4:45 PM
0 · Reply
Masonic11
Masonic11 May. 20 at 11:48 PM
$ALP $TRNX $TRNFQ $INTS Dear $ALP investor: Throughout the history of this company. There are multiple connections to the many faces of $ALP. There has been intertwined leadership roles with prior management, that didn't end well, with Portage's cancer technology taken private. There is ATON/Portage biotech/BBHC/TRNX / TRNFQ / INTS connections that haven't been brought to light, (yet.) There is amazing IP for clean energy, precious metal recovery, leading to the sterilization of waste water. I initially invested heavily in $TRNX as a young plumber working on large farms, seeing the potential benefits of cleaning up all of the agricultural waste, (large quantities of manure.) I'm all in in this rebrand, as this leadership has the connections we need to be a major player, in confidential computing power. Dive down the rabbit 🐇 hole if you wish. I've been connected with all of this for 7 years...👽
1 · Reply
Masonic11
Masonic11 May. 20 at 11:32 PM
0 · Reply
NVDAMillionaire
NVDAMillionaire May. 20 at 7:42 PM
$INTS Outstanding article that hits the mark on INTS's current state. So if you want to refresh your INTS insights or learn about INTS from scratch, this is a must read. https://everyticker.com/quote/INTS/analysis/intensity-therapeutics-promising-science-meets-the-funding-cliff-nasdaq-ints
1 · Reply
SBEEE
SBEEE May. 19 at 3:52 PM
$INTS Looks like CEO is leaving for vacation and he’s going to be back on October 1st. WOW. https://www.discoveryontarget.com/drug-modalities
1 · Reply
joel12365
joel12365 May. 18 at 12:47 PM
$INTS well jelous my average is 10
0 · Reply
ProfitMaker4
ProfitMaker4 May. 18 at 11:54 AM
$INTS continuing to buy sub $5.
0 · Reply
DyllyDylly99
DyllyDylly99 May. 15 at 6:19 PM
$INTS I’m in - good luck to me
1 · Reply
Pettechfl
Pettechfl May. 13 at 3:05 PM
$INTS whats with the selling?
1 · Reply
Straightt_Cash_Homie
Straightt_Cash_Homie May. 12 at 3:29 PM
$INTS This might be the worst and most suspiciously traded stock i‘ve ever invested in. Hope im wrong.
1 · Reply
TNNSTrade
TNNSTrade May. 8 at 8:18 PM
$INTS Everything seems on track. We just need to find some momentum. Enjoy the weekend!
1 · Reply
Pettechfl
Pettechfl May. 7 at 10:47 PM
https://www.prnewswire.com/news-releases/intensity-therapeutics-reports-first-quarter-2026-financial-results-and-provides-corporate-update-302766229.html $INTS
0 · Reply